[PHARMA] YoY Annual (Unaudited) Result on 31-Dec-2019 [#4]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
20-Feb-2020
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2019
Quarter
31-Dec-2019 [#4]
Profit Trend
YoY- -451.37%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annual (Unaudited) Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 3,510,677 4,815,015 2,725,071 2,820,530 2,384,956 2,323,960 2,189,022 8.18%
PBT -580,846 277,075 35,793 -191,865 70,220 73,064 72,017 -
Tax -24,204 -104,870 -9,524 42,418 -26,990 -17,977 -26,158 -1.28%
NP -605,050 172,205 26,269 -149,447 43,230 55,087 45,859 -
-
NP to SH -607,317 172,150 27,489 -149,219 42,468 53,823 45,599 -
-
Tax Rate - 37.85% 26.61% - 38.44% 24.60% 36.32% -
Total Cost 4,115,727 4,642,810 2,698,802 2,969,977 2,341,726 2,268,873 2,143,163 11.48%
-
Net Worth -248,894 450,411 337,298 336,573 509,862 526,888 531,169 -
Dividend
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Div 24,889 121,768 28,761 22,177 41,621 49,314 41,457 -8.14%
Div Payout % 0.00% 70.73% 104.63% 0.00% 98.01% 91.62% 90.92% -
Equity
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Net Worth -248,894 450,411 337,298 336,573 509,862 526,888 531,169 -
NOSH 1,309,126 1,309,126 261,705 261,229 260,505 259,821 259,377 30.95%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -17.23% 3.58% 0.96% -5.30% 1.81% 2.37% 2.09% -
ROE 0.00% 38.22% 8.15% -44.33% 8.33% 10.22% 8.58% -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
RPS 268.00 367.74 1,042.20 1,081.04 916.82 895.38 844.83 -17.40%
EPS -46.36 13.15 10.51 -57.19 16.33 20.74 17.60 -
DPS 1.90 9.30 11.00 8.50 16.00 19.00 16.00 -29.87%
NAPS -0.19 0.344 1.29 1.29 1.96 2.03 2.05 -
Adjusted Per Share Value based on latest NOSH - 261,229
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
RPS 243.58 334.08 189.08 195.70 165.48 161.25 151.88 8.18%
EPS -42.14 11.94 1.91 -10.35 2.95 3.73 3.16 -
DPS 1.73 8.45 2.00 1.54 2.89 3.42 2.88 -8.14%
NAPS -0.1727 0.3125 0.234 0.2335 0.3538 0.3656 0.3685 -
Price Multiplier on Financial Quarter End Date
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Date 30/12/22 31/12/21 31/12/20 31/12/19 31/12/18 29/12/17 30/12/16 -
Price 0.545 0.74 5.00 2.06 2.78 4.60 5.30 -
P/RPS 0.20 0.20 0.48 0.19 0.30 0.51 0.63 -17.39%
P/EPS -1.18 5.63 47.56 -3.60 17.03 22.18 30.12 -
EY -85.07 17.77 2.10 -27.76 5.87 4.51 3.32 -
DY 3.49 12.57 2.20 4.13 5.76 4.13 3.02 2.43%
P/NAPS 0.00 2.15 3.88 1.60 1.42 2.27 2.59 -
Price Multiplier on Announcement Date
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Date 27/02/23 17/02/22 17/03/21 20/02/20 21/02/19 27/02/18 21/02/17 -
Price 0.44 0.76 3.49 2.04 2.76 4.04 5.12 -
P/RPS 0.16 0.21 0.33 0.19 0.30 0.45 0.61 -19.98%
P/EPS -0.95 5.78 33.20 -3.57 16.91 19.48 29.09 -
EY -105.37 17.30 3.01 -28.04 5.92 5.13 3.44 -
DY 4.32 12.24 3.15 4.17 5.80 4.70 3.13 5.51%
P/NAPS 0.00 2.21 2.71 1.58 1.41 1.99 2.50 -

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment